Complexity of signal transduction mediated by ErbB2: Clues to the potential of receptor-targeted cancer therapy

This publication has 142 references indexed in Scilit:

• Endocytosed Epidermal Growth Factor (EGF) Receptors Contribute to the EGF-Mediated Growth Arrest in A431 Cells by Inducing a Sustained Increase in p21/CIP1
  Experimental Cell Research, 1998
• ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
  The EMBO Journal, 1997
• The Relationship between Human Epidermal Growth-like Factor Receptor Expression and Cellular Transformation in NIH3T3 Cells
  Journal of Biological Chemistry, 1996
• Neu Differentiation Factor/Neuregulin Isoforms Activate Distinct Receptor Combinations
  Published by Elsevier ,1996
• Intracellular Trafficking of Epidermal Growth Factor Family Ligands Is Directly Influenced by the pH Sensitivity of the Receptor/Ligand Interaction
  Journal of Biological Chemistry, 1995
• Colocalization of the p185^HER2 oncoprotein and integrin α6β4 in Calu‐3 lung carcinoma cells
  Journal of Cellular Biochemistry, 1994
• Estrogen suppression of erbB2 expression is associated with increased growth rate of ZR‐75‐1 human breast cancer cells in vitro and in nude mice
  International Journal of Cancer, 1991
• Long‐term survival in breast cancer related to overexpression of the c‐erbB‐2 oncoprotein: An immunohistochemical study using monoclonal antibody NCL‐CB11
  The Journal of Pathology, 1991
• Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
  Science, 1987
• Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies
  Cell, 1985